Stock listing
NASDAQ:SRDX SurModics Inc Stock
Follow SurModics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SRDX
$42.98 USD
Close on Nov 18, 2025 · No longer trades
- Lowest – highest close
- $8.33 – $80.35 USDSince Dec 7, 2000 · lowest Nov 16, 2010 · highest Sep 13, 2018
Delisted NASDAQ:SRDX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SRDX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
SurModics Inc on 6ix
- Calls
- 14 calls with a replay · 14 with a transcript · latest May 1, 2024
- Decks
- 9 decks · latest Jun 8, 2023
Events
| Call | When | Status |
|---|---|---|
| SurModics (SRDX) Q2 2024 Earnings Call | Wed, May 01, 2024 · 8:00 AM ET | Replay |
| SurModics (SRDX) Q1 2024 Earnings Call | Thu, Feb 01, 2024 · 8:00 AM ET | Replay |
| SurModics (SRDX) Q4 2023 Earnings Call | Wed, Nov 08, 2023 · 8:00 AM ET | Replay |
| SurModics (SRDX) Q3 2023 Earnings Call | Wed, Aug 02, 2023 · 8:00 AM ET | Replay |
| SurModics (SRDX) Q2 2023 Earnings Call | Wed, Apr 26, 2023 · 8:00 AM ET | Replay |
| SurModics (SRDX) Q1 2023 Earnings Call | Mon, Feb 06, 2023 · 5:00 PM ET | Replay |
| SurModics (SRDX) Q4 2022 Earnings Call | Wed, Nov 09, 2022 · 8:00 AM ET | Replay |
| SurModics (SRDX) Q3 2022 Earnings Call | Wed, Jul 27, 2022 · 8:30 AM ET | Replay |
| SurModics (SRDX) Q2 2022 Earnings Call | Wed, Apr 27, 2022 · 8:30 AM ET | Replay |
| SurModics (SRDX) Q1 2022 Earnings Call | Thu, Feb 03, 2022 · 8:30 AM ET | Replay |
All 14 calls
| Call | When | Status |
|---|---|---|
| SurModics (SRDX) Q4 2021 Earnings Call | Wed, Nov 10, 2021 · 8:30 AM ET | Replay |
| SurModics (SRDX) Q3 2021 Earnings Call | Wed, Aug 04, 2021 · 8:30 AM ET | Replay |
| SurModics (SRDX) Q2 2021 Earnings Call | Wed, Apr 28, 2021 · 8:30 AM ET | Replay |
| SurModics (SRDX) Q1 2021 Earnings Call | Tue, Feb 09, 2021 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2023) | Investor deck | 43 slides | Jun 8, 2023 |
| Investor Presentation (March 2023) | Investor deck | 42 slides | Mar 15, 2023 |
| Investor Presentation (January 2022) | Investor deck | 46 slides | Jan 11, 2022 |
| Merger or Acquisition (July 2021) | Merger or acquisition | 15 slides | Jul 6, 2021 |
| Investor Presentation (August 2019) | Investor deck | 30 slides | Aug 13, 2019 |
| Investor Presentation (April 2019) | Investor deck | 31 slides | Apr 9, 2019 |
| Technical Presentation (November 2018) | Technical | 16 slides | Nov 7, 2018 |
| Investor Presentation (November 2011) | Investor deck | 36 slides | Nov 29, 2011 |
| Investor Presentation (September 2011) | Investor deck | 32 slides | Sep 14, 2011 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Scott R. Ward Other companies: Merit Medical Systems, Inc. (Member - Governance & Sustainability Committee, Finance & Operating Committee · Since at least May 13, 2026); InspireMD Inc. (Board Member · Since at least Nov 25, 2024); Cardiovascular Systems Inc (Chairman and CEO, Director · Nov 13, 2013 – Apr 27, 2023 · Past); Medtronic plc. (SVP & Pres CardioVascular · Apr 30, 2010 – Apr 30, 2010 · Past) | Director · Sep 20, 2010 – Dec 3, 2014 · Past |
| Lisa Wipperman Heine Other companies: Miromatrix Medical Inc (Director · Dec 12, 2023 – Dec 12, 2023 · Past) | Director · Since at least Feb 8, 2024 |
| Mary K Brainerd Other companies: Stryker Corporation (Director · Since at least Aug 1, 2017) | Director · Feb 2, 2009 – Nov 18, 2013 · Past |
| Robert C Buhrmaster Other companies: Toro Company (the) (Director · Oct 27, 2008 – Mar 18, 2019 · Past) | Director · Nov 17, 2008 – Feb 4, 2014 · Past |
| Amy E Seibert | Principal Accounting Officer · Apr 28, 2015 – Apr 28, 2016 · Past |
| Charles W Olson | SVP, Medical Device Coatings · Since at least Nov 25, 2022 |
| David Dantzker | Director · Since at least Jan 19, 2024 |
| Gordon S Weber | Sr. VP of Legal, GC and Sec. · Since at least May 11, 2020 |
| Gregg S Sutton | VP of Research and Development · Jan 8, 2016 – Nov 27, 2019 · Past |
| Jan M Webster | VP of HR · Nov 30, 2010 – Nov 30, 2010 · Past |
All 14 people
| Person | Seat |
|---|---|
| John D Manders | VP Finance, Corp. Controller · Since at least Nov 25, 2020 |
| Nusrath Sultana | VP, Clinical Affairs · Nov 30, 2020 – Feb 12, 2022 · Past |
| Susan E Knight | Director · Since at least Dec 18, 2015 |
| Timothy J Arens | Chief Financial Officer · Since at least Nov 19, 2025 |
Log in to ask 6ix AI your own questions about SurModics Inc.